CRISPR Therapeutics AG (CRSP)

NASDAQ: CRSP · Real-Time Price · USD

56.89

+0.71 (1.26%)

At close: Jan 14, 2026, 4:00 PM EST

56.76

-0.13 (-0.23%)

After-hours: Jan 14, 2026, 7:59 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2013 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2013 - 2019
Genome-editing Technology	37.31M	Log In	Log In	Log In	Log In	Upgrade
Genome-editing Technology Growth	-89.95%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2013 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2013 - 2019
Switzerland and United States	37.31M	Log In	Log In	Log In	Log In	Upgrade
Switzerland and United States Growth	-89.95%	Log In	Log In	Log In	Log In	Upgrade